CSIMarket


Stealth Biotherapeutics Corp  (MITO)
Other Ticker:  
 

Stealth Biotherapeutics Corp

MITO's Fundamental analysis








Looking into Stealth Biotherapeutics growth rates, revenue grew in IV. Quarter 2021 from the same quarter a year ago.

Major Pharmaceutical Preparations industry recorded growth of revenues by 29.91 %

Stealth Biotherapeutics net loss deacreased by in IV. Quarter 2021 year on year, Stealth Biotherapeutics net loss increased by -8.58 % in IV. Quarter 2021 year on year,

More on MITO's Growth


Stealth Biotherapeutics
realized net loss in trailing twelve months.

Company
PE TTM   
Industry
268.03
PE TTM    
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.7.


More on MITO's Valuation
 
 Total Debt (Millions $) 14
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ -
 Net Income/Employee (TTM) $ -
 Receivable Turnover (TTM) -
 Tangible Book Value (Per Share $)

Stealth Biotherapeutics
realized net loss in trailing twelve months.

Company
PE TTM   
Industry
268.03
PE TTM    
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.7.